[go: up one dir, main page]

ZA975804B - Novel use of active substances which influence the functions of non-neuronal acetylcholine. - Google Patents

Novel use of active substances which influence the functions of non-neuronal acetylcholine.

Info

Publication number
ZA975804B
ZA975804B ZA9705804A ZA975804A ZA975804B ZA 975804 B ZA975804 B ZA 975804B ZA 9705804 A ZA9705804 A ZA 9705804A ZA 975804 A ZA975804 A ZA 975804A ZA 975804 B ZA975804 B ZA 975804B
Authority
ZA
South Africa
Prior art keywords
influence
functions
active substances
novel use
neuronal acetylcholine
Prior art date
Application number
ZA9705804A
Inventor
Ignaz Wessler
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of ZA975804B publication Critical patent/ZA975804B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA9705804A 1996-07-02 1997-06-30 Novel use of active substances which influence the functions of non-neuronal acetylcholine. ZA975804B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19626373A DE19626373A1 (en) 1996-07-02 1996-07-02 Novel use of active ingredients that affect the function of non-neuronal acetylcholine

Publications (1)

Publication Number Publication Date
ZA975804B true ZA975804B (en) 1998-01-02

Family

ID=7798569

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9705804A ZA975804B (en) 1996-07-02 1997-06-30 Novel use of active substances which influence the functions of non-neuronal acetylcholine.

Country Status (4)

Country Link
AU (1) AU3263297A (en)
DE (1) DE19626373A1 (en)
WO (1) WO1998000119A2 (en)
ZA (1) ZA975804B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999008672A1 (en) * 1997-08-15 1999-02-25 Shire International Licensing Bv Use of cholinesterase inhibitor for treating diseases associated with proteolytic enzyme activity
GB9918760D0 (en) * 1999-08-09 1999-10-13 Darwin Discovery Ltd Topical treatment
US6277855B1 (en) * 2000-04-21 2001-08-21 Inspire Pharmaceuticals, Inc. Method of treating dry eye disease with nicotinic acetylcholine receptor agonists
DE10111843A1 (en) 2001-03-13 2002-09-19 Boehringer Ingelheim Pharma Compounds for the treatment of inflammatory diseases
JPWO2003066100A1 (en) * 2002-02-07 2005-05-26 エーザイ株式会社 Hair growth promoter, preparation for transdermal application, and method for promoting hair growth
US20050222123A1 (en) * 2004-01-27 2005-10-06 North Shore-Long Island Jewish Research Institute Cholinesterase inhibitors for treating inflammation
EP1807087A2 (en) * 2004-10-12 2007-07-18 Ernir Snorrason Inhibitors of acetylcholinesterase for treating skin diseases
GB2419093A (en) * 2004-10-12 2006-04-19 Ernir Snorrason Acetylcholinesterase inhibitors for the treatment of skin
HUE038899T2 (en) * 2013-03-15 2018-12-28 Verona Pharma Plc Drug combination
WO2017195783A1 (en) * 2016-05-09 2017-11-16 株式会社ナノエッグ Composition for treating or preventing atopic dermatitis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1243729A1 (en) * 1984-06-01 1986-07-15 Киевский государственный институт усовершенствования врачей Method of treatment of neurodermite
US5084281A (en) * 1989-02-14 1992-01-28 Dillon Richard S Method and solution for treating tissue wounds
US5185350A (en) * 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US5550112A (en) * 1992-12-30 1996-08-27 Patent Biopharmaceutics, Inc. Hyaluronic acid-urea pharmaceutical compositions and uses

Also Published As

Publication number Publication date
AU3263297A (en) 1998-01-21
DE19626373A1 (en) 1998-01-08
WO1998000119A2 (en) 1998-01-08
WO1998000119A3 (en) 1998-04-02

Similar Documents

Publication Publication Date Title
ZA975947B (en) Aqueous-based pharmaceutical composition.
ZA9710071B (en) Pharmaceutical composition.
ZA9710927B (en) Pharmaceutical composition.
ZA979985B (en) N-substituted 2-cyanopyrrolidines.
ZA964710B (en) Novel compounds, the preparation and use thereof.
ZA9710322B (en) Process for the preparation of benzyl-ethers.
ZA973209B (en) Therapeutic compounds.
ZA975804B (en) Novel use of active substances which influence the functions of non-neuronal acetylcholine.
ZA971997B (en) Resolution of threo-methylphenidate.
ZA974811B (en) Novel therapeutic compounds.
ZA96796B (en) Transdermal formulation.
GB9601062D0 (en) The updrifter
ZA976350B (en) Treatment of liquid.
EP0653246A3 (en) Atomizer.
ZA969315B (en) Processes and intermediates for the preparation of ziprasidone.
GB9726223D0 (en) The treatment of materials
GB2316170B (en) The detection of volatile substances
ZA975001B (en) Preparation of Alpha-fluoroketones.
ZA978504B (en) Assay.
ZA94434B (en) Pharmaceutical composition.
ZA979839B (en) The measuring out of substances.
ZA979693B (en) Diagnostic composition.
GR2001639Y (en) Angular bathtub.
ZA979447B (en) Pharmaceutical composition.
ZA966486B (en) Pharmaceutical Composition.